(Q40093656)

English

Everolimus and mycophenolate mofetil sensitize human pancreatic cancer cells to gemcitabine in vitro: a novel adjunct to standard chemotherapy?

scientific article published on 14 August 2007

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Everolimus and mycophenolate mofetil sensitize human pancreatic cancer cells to gemcitabine in vitro: a novel adjunct to standard chemotherapy? (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

pancreatic cancer

1 reference

based on heuristic

inferred from title

author name string

P Tuncyurek

1

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

J M Mayer

2

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

F Klug

3

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

S Dillmann

4

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

D Henne-Bruns

5

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

F Keller

6

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

S Stracke

7

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

14 August 2007

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

European Surgical Research

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

39

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

380-387

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Gemcitabine versus cisplatin, epirubicin, fluorouracil, and gemcitabine in advanced pancreatic cancer: a randomised controlled multicentre phase III trial

1 reference

https://api.crossref.org/works/10.1159%2F000107356

21 January 2018

Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.1159%2F000107356

21 January 2018

Dual inhibition of mTOR and estrogen receptor signaling in vitro induces cell death in models of breast cancer

1 reference

https://api.crossref.org/works/10.1159%2F000107356

21 January 2018

Antitumor efficacy of intermittent treatment schedules with the rapamycin derivative RAD001 correlates with prolonged inactivation of ribosomal protein S6 kinase 1 in peripheral blood mononuclear cells.

1 reference

https://api.crossref.org/works/10.1159%2F000107356

21 January 2018

Renal proximal tubular cell growth and differentiation are differentially modulated by renotropic growth factors and tyrosine kinase inhibitors

1 reference

https://api.crossref.org/works/10.1159%2F000107356

21 January 2018

mTOR-targeted therapy of cancer with rapamycin derivatives

1 reference

https://api.crossref.org/works/10.1159%2F000107356

21 January 2018

Mammalian target of rapamycin inhibition as therapy for hematologic malignancies

1 reference

https://api.crossref.org/works/10.1159%2F000107356

21 January 2018

Targeting the mammalian target of rapamycin (mTOR): a new approach to treating cancer

1 reference

https://api.crossref.org/works/10.1159%2F000107356

21 January 2018

The mTOR inhibitor RAD001 sensitizes tumor cells to DNA-damaged induced apoptosis through inhibition of p21 translation.

1 reference

https://api.crossref.org/works/10.1159%2F000107356

21 January 2018

Identifiers

10.1159/000107356

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40093656&oldid=1633141875"